Before COVID-19, telemedicine was practiced by many health systems, but seeing patients in person was still the norm.
Within a few short weeks in March 2020, health systems and practices were forced to adopt new ways of seeing patients and delivering care.
Although face-to-face visits will always be a part of health care, thereâs no going back, providers say.Â
There are still obstacles that need to be overcome â especially when it comes to insurance coverage and access.
Nevertheless, the pandemic is spurring advances in delivery of patient care that might otherwise have taken years to develop.
VIDEO AND MONITORING
âPre-COVID, we were interested in making telehealth part of our five-year plan,â said Dr. Christopher Davis, UCHealth emergency medicine physician and medical director of virtual health. âThat was critical when COVID hit in March, because we had infrastructure in place that we could rapidly scale rather than building from scratch.â
The New England Journal of Medicine published favorable clinical trial data about Johnson & Johnson s potential Covid-19 vaccine, including data about safety and immune response, CNBC. | January 14, 2021
Targeted strategy has potential to reduce disparities in breast cancer screening rates
Completing cancer screening tests, such as mammograms, can be challenging for low-income people, who may face such challenges as lack of transportation or inability to take time off work. A team at Massachusetts General Hospital (MGH) explored the possibility of addressing preventive care needs when patients are admitted to the hospital.
The pilot study, published in the
Annals of Family Medicine, examined the feasibility of performing mammograms in women insured by Medicaid or both Medicaid and Medicare (dual-eligible patients) while they were hospitalized.
We designed the study to reach the patients who face significant barriers to completing their mammograms in the outpatient setting. National and local data show that Medicaid and dual-eligible patients have low rates of breast cancer screening. This targeted strategy has the potential to reduce disparities in cancer screening rates by addr
Crowdfunding boosts Te Horo based medicinal cannabis company Phytotecnia
14 Jan, 2021 12:40 AM
2 minutes to read
Irene Lopez-Ubiria and Alvaro Vidiella-Salaberry. Photo / Supplied
David Haxton is editor of Kapiti Newsdavid.haxton@nzme.co.nz
A medicinal cannabis company based in Te Horo, north of Wellington, has proved very popular with the public.
Agricultural engineers Irene Lopez-Ubiria and Alvaro Vidiella-Salaberry sought crowdfunding for their Phytotecnia Ltd company via PledgeMe which started midway in November last year.
They thought they might be lucky to raise $500,000 but have been humbled with over $860,000 so far. We are super happy and many local people are supporting us too, Irene said.